Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

Автор: Хомов Д.А.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 1 т.10, 2010 года.

Бесплатный доступ

Состояние желудочно-кишечного тракта на современном этапе развития онкологии изучено в недостаточной степени. Органы желудочно-кишечного тракта, являясь одними из наиболее радио- и химиочувствительных, страдают при применении любой схемы лечения и, если оценка состояния их в процессе лечения и проводится, то только при наличии жалоб пациента. В данной работе предпринята попытка описания эндоскопической картины всего желудочно-кишечного тракта в процессе и после химиолучевого лечения.

Желудочно-кишечный тракт, эндоскопическая диагностика, лимфома ходжкина, химиолучевое лечение

Короткий адрес: https://sciup.org/14955193

IDR: 14955193

Список литературы Эндоскопическая диагностика состояния желудочно-кишечного тракта у больных лимфомой Ходжкина в процессе химиолучевого лечения. Литературный обзор

  • Байсоголов Г.Д., Шахтарина С.В. Лечение больных лимфогранулематозом III Б стадии//Мед. радиол. и радиац. безоп.-1994.-т.39.-№1.-с.41-46.
  • Байсоголов Г.Д., Шахтарина С.В., Павлов В.В. Лечение лимфогранулематоза I-IV стадии//Мед. радиол.-1992.-т.37.-№3-4.-с.27-28.
  • Гершанович М.Л. Осложнения при химио-и гормонотерапии злокачественных опухолей.-М.: Медицина, 1982, 224 с.
  • Даценко П.В. Расширенная радикальная программа лучевой терапии с профилактическим облучением легких у больных лимфогранулематозом//Диссертация на соискание ученой степени кандидата медицинских наук.-Москва.-1994.
  • Даценко П.В. Сбалансированное сочетание лучевого и лекарственного компонентов при комплексном лечении лимфогранулематоза. Дисс. д-ра мед. наук.-М.-2004.-235 с.
  • Демина Е.А. Современное лечение первичных больных лимфомой Ходжкина//VII Росс. онкол. Конгресс.-Москва.-2003.-С.103-108.
  • Демина Е.А., Ткачев С.И., Трофимова О.П. и др. Комбинированная химиолучевая терапия первичных больных лимфомой Ходжкина//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.121-125.
  • Ильин Н.В. Лимфома Ходжкина (болезнь Ходжкина) (лекция, часть I)//Вестник гематологии. -2006. -т.2, №4. -С.51-58.
  • Ильин Н.В. Лимфома Ходжкина (болезнь Ходжкина) (лекция, часть II)//Вестник гематологии. -2006. -т.3, №1. -С.65-70.
  • Ильин Н.В., Виноградова Ю.Н. Поздние осложнения терапии больных лимфомой Ходжкина//Практическая онкология. -2007. -т.8 №2. -С.96-101.
  • Канаев С.В, Гершанович М.Л., Гиршович М.М., Голованов С.Г. Клиническая оценка эффективности химиолучевого лечения лимфомы Ходжкина III стадии//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.118-120.
  • Переслегин И.А., Филькова Е.М. Лимфогранулематоз. М., 1980.
  • Мельник Ю.Д. Новые программы лучевого и лекарственного лечения лимфогранулематоза.//Автореф. дисс. к.м.н., Москва, 2006.
  • Пробатова Н.А. Морфологические критерии диагностики лимфомы Ходжкина//VI ежегодная Росс. онкол. конф.-Тез. докл.-Москва.-2002.-С. 46 -47.
  • Тумян Г.С., Тупицин Н.Н, Пробатова Н.А и др. Клиническая и иммуноморфологическая характеристика двух различных форм лимфомы Ходжкина//VI ежегодная Росс. онкол. конф.-Тез. докл.-Москва.-2002.-С. 47 -49.
  • Харченко В.П., Паньшин Г.А., Сотников В.М., Даценко П.В. Опыт и перспективы расширенной радикальной программы лучевой терапии с профилактическим облучением легких и печени у больных лимфогранулематозом.//Вопр. онкол.-2000.-Т.46.-№6.-С.718-723.
  • Харченко В.П., Паньшин Г.А., Сотников В.М., Даценко П.В. Роль лучевой терапии в лечении IV стадии болезни Ходжкина//VIII Росс. Онкол. Конгресс.-Москва.-2004.-С.120.
  • Щербенко О. И., Пархоменко Р.А., Зелинская Н.И., Снигирева Р.Я., Ардатова Г.В., Халиль Е.Ф., Скворцова О.Ю., Сычева Н.А.,Пуртова Г.С., Зуева А.В., Кошкин В.Ф., Снигирев Я.В. Отдаленные последствия химиолучевого лечения лимфогранулематоза у детей//VII Росс. Научн. форум Радиология.-Москва.-2006.-С. 270.
  • Aisenberg A.C. Problems in Hodgkin's disease management//Blood.-1999.-v.93.-n.3.-p.761-779.
  • Aleman B.M.P, van den Belt-Dusebout A.W., Klokman W.J., et. al. Late cardiotoxity after treatment for Hodgkin lymphoma.//Blood..-2007.-Vol.109(5). -P.1878-1886.
  • Aleman B.M., Belt-Dusebout A.W., Klakman W.J. at al. Long-term cause-specific mortality of patients treated for Hodgkin's disease//J.Clin. Oncol. -2003. -Vol.21 -P.3431-3439
  • Allen-Mersh TG, Wilson EJ, Hope-Stone HFel al. (1986) Has the incidence of radiation-induced bowel damage following treatment of uterine carcinoma changed in the last 20 years?.1 R Soc Med 79: 387 390
  • Andrieu J.M., Jais J.P., Colonna P., et al. Ten-year results of strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages//Ann Oncol.-1998.-v.9-p.195-203.
  • Andrieu J.M., Weh H.J., Tiellet F., et al. Localisation pulmonaire de la maladie de Hodgkin. Aspects initiaux et evolution//La Nouv. Presse Med.-1978.-v.7-p.3737-3741.
  • Anno G.H., Daum S.J., Withers H.R. et al. Symptomatology of acute Radiation Effects in Humans After Exposure to Doses of 0,5-30Gy. Health Physics 1989. -V.56.-N.6. -P.821-838
  • Aversa S. M., Salvagno L., Soraru M., at al. Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.//Acta Haematol., 2004, v. 112(3), p. 141-147.
  • Ballova V., Ruffer J.U., Haverkamp H., at al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).//Ann Oncol., 2005, v. 16(1), p. 124-31.
  • Barlett N.L., Rosenberg S.A., Hoppe R.T., et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report//J. Clin. Oncol.-1995.-v.13.-p.1080-1088.
  • Behar R.A., Horning S.J., Hoppe R.T., et al. Hodgkin's disease with bulky mediastinal involvement: Effective management with combined modality therapy//Jnt. J. Radiat Oncol Biol. Phys.-1993.-v.25.-p.771.
  • Boivin J.F., Hutchison G.B., Lubin J.H., Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease//Cancer.-1992.-v.69-p.1241-1247.
  • Burger A, Loeffler H, Bamberg M, et al: Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 73:401-408, 1998
  • Canellos G. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?//Leukemia.-1996.-v.10.-(Suppl 2).-p.68.
  • Canellos G., Anderson J., Propert K., et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD//N Eng J Med.-1992.-v.327-p.1478.
  • Carbone P.P., Kaplan H.S., Musshoff K. et al., Report of the committee on Hodgkin' s disease staging classification.//Cancer Res. -1971. -V.31. -P.1860.
  • Canellos G.P.,.Lister T.A., Sklar J.L. The Lymphomas, W.B.Saunders Comp. 1998.
  • Carella A.M., Prencipe E., Pungolino E., et al. Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy//Leukemia and Lymphoma.-1996.-v.21.-N.1-2.-p.63-70
  • Chittal S. M., Alard C. et al.//Amer. J. Sur. Path., 190, v. 14 (11), p. 1024
  • Chopra R., McMillan A.K., Linch D.C., et al. The place high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients//Blood.-1993.-v.81.-p.1137
  • Cosset J.M., Henry-Amar M., Pellae-Cosset B., et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy//Jnt. J. Radiat Oncol. Biol. Phys.-1991.-v.21.-p.447-449.
  • Canellos G.P.,.Lister T.A., Sklar J.L. The Lymphomas, W.B.Saunders Comp. 1998.
  • De Vita V.T., Hellman S., Rosenberg S.A. Cancer: Principles Practice of Oncology. 4th Edition.//Philadelphia.-1993.-V.2.-P. 1819-1858.
  • De Vita V.T., Hellman S., Rosenberg S.A. Cancer: Principles Practice of Oncology. 6th Edition.//Philadelphia: Lippincott-Raven Publishers.-2001.-chapter 45.
  • Diehl V., Franklin J., Hasenclever D., et al. BEACOPP: A new regimen for advanced Hodgkin's disease//Annals of Oncology. -1998.-v.9.-(Suppl.5).-p.67-71.
  • Diehl V., Franklin J., Paulus U., et. al. Dose escalated BEACOPP chemotherapy regimen for advanced stage Hodgkin's disease: final analysis of the HD9 randomized trial of the GHSG.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
  • Dimitrievich GS, Fischer-Dzoga K, Griem ML: Radiosensitivity of vascular tissue: I-Differential radiosensitivity of capillaries: A quantitative in vivo study. Radiat Res 99:511-535, 1984
  • Doubleday LC, Bernardino ME (1980) CT findings in the peri-rectal area following radiation therapy. J Comput Assist Tomogr 4: 634-638
  • DuBrow RA (1994) Radiation changes in the hollow viscera. Semin Roentgenol 29: 38-52
  • Jaenke RS, Robbins ME, Bywaters T, et al: Capillary endothelium: Target site of renal radiation injury. Lab Invest 68:396-405, 1993
  • Jaffe E., Harris N., Stein H., Vardiman J.//IACR Press, 2001, Lyon.
  • Josting A., Wiedenmann S., Franklin J., at al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.//J. Clin. Oncol., 2003, vol. 21 (18), p. 3440-3446.
  • Josting A., Behringer K, Engert A, Diehl V. Modern pharmacotherapy of Hodgkin disease.//Internist (Berl), 2004, v. 45(1), p. 93-101.
  • Economopoulos T., Fountzilas G., Dimopoulos M.A., at al. Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group.//Eur. J. Haematol., 2003, v. 71(4), p. 257-262.
  • Eich H.T., Muller R.P., Ansen S., at al. New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology//Rontgenpraxis, 2003, v. 55(3), p. 114-24.
  • Fabian C.J., Mansfield C.M., Dahlberg S., et al. Low-dose involved field radiation after chemotherapy in advanced Hodgkin's disease//Ann Intern Med.-1994.-v.120.-p.903.
  • Fajardo LF, Bathrong M, Anderson RE: Radiation Pathology. New York, Oxford University Press, 2001
  • Fishman EK, Zinreich ES, Jones В et al. (1984) Computed! tomographic diagnosis of radiation ileitis. Gastrointest Radiol 9: Р.149-152
  • Fournier C, Scholz M, Kraft-Weyrather W, et al: Changes of fibrosisrelated parameters after high and low LET irradiation of fibroblasts. Int J Radiat Biol 77:713-722, 2001
  • Franklin., Diehl V.//Annals of oncology, 1996, v.3, p. 39.
  • Fuller L.M., Hagemeister F.B., North L.B., et al. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage I through IIB Hodgkin's disease: Preliminary result//Jnt. J. Radiat. Oncol.-Biol.-Phys.-1988.-Vol.14.-p. 683-692.
  • Gilinsky NH, Burns DG, Barbezat GO et al. (1983) The natural history of radiation-induced proctosigmoiditis: an analyiss of 88 patients. Q J Med New Series 52: 40-53.
  • Glick J., Young M., Harrington D., et al. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year results of intergroup trial//J. Clin. Oncol. -1998.-v.16.-p.19-26.
  • Goldstein IIM, Rogers LF, Fletcher GH ct al. (1975) Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract. Radiology 117: 135-140
  • Goldstone A.H. The case for and against high-dose therapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission//Annals of Oncology.-1998.-v.9.-(Suppl.5).-p.83-85.
  • Gospodorowicz M.K., Sutcliffe S.B., Clark R.M., et al. Analysis of supradiaphragmatic clinical stages I and II Hodgkin's disease treated with radiation alone//Jnt. J. Radiat Oncol. Biol. Phys.-1992.-v.22.-p.859.Hakenjos L, Bamberg M, Rodemann HP: TGF-_1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic response. Int J Radiat Biol 76:503-509, 2000
  • Hancock S.L., Hoppe R.T. Long-tern complications of treatment and causes of mortality after Hodgkin's disease//Semin Radiat. Oncol.-1996.-v.6.-p.225
  • Hauer-Jensen M (1990) Late radiation injury of the small intestine: clinical, pathophysiologic and radiobiologic aspects. ActaOncol 29: 401-415
  • Henkelmann G.C., Hagemeister F.B., Fuller L.M. Two cycles of MOPP and radiotherapy for stage IIIA and IIIB Hodgkin's disease.//J. Clin. Oncol.-1988.-Vol 6.-P. 1293-1302.Herskind C, Bentzen SM, Overgaard J, et al: Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 47:263-269, 1998
  • Henry-Amar M. Second cancer after treatment Hodgkin's disease: A report from the International Database on Hodgkin's disease//Ann Oncol.-1992.-v.3.-(Suppl.4).-p.117.
  • Henry-Amar M., Joly F. Late complications after Hodgkin's disease//Ann Oncol.-1996.-v.7.-(Suppl.4).-p.115.
  • Herskind C, Johansen J, Bentzen SM, et al: Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol 39:383-388, 2000
  • Hodgkin T. On some morbid appearances of the absorbent glands and spleen//Med-Chir. Trans.-1832.-v.17.-p.68.
  • Hoppe R.T. Hodgkin's disease: Second cancer after treatment Hodgkin's disease: Complications of therapy and excess mortality//Ann Oncol.-1997.-v.8.-(Suppl.1).-p.115.
  • Hoppe R.T. Hodgkin's disease: Radiation therapy in the management of Hodgkin's disease//Semin Oncol.-1990.-v.17.-p.704.
  • Horning S., Rosenberg S., Hoppe R. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update // Ann Oncol.- 1996.-v.7.-(Suppl.4).-p.105. Hoskin P.J., Smith P., Linch D.C. Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone.// Ann. of Oncology.- 2002.- v13.-suppl.2.- p.-65.
  • Jaen J, Santos JA, Carrion JR ct al. (1989) Severe small bowel radiation enteritis. Acta Oncol 28: 717-720
  • Kaplan H.S. Hodgkin's Disease.//Harvard University Press., Cambridge, Massachusetts, London, England, 1980.
  • Kanzler H., Kϋppers R., Hansmann M.L. et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 1996, 184, P.1495-1505. Konstantinidou P, Verrou E., Georgio E. et al. Prevalence of hepatitis B in with Hodgkin and non-Hodgkin's lymphomas//Haematologia. -2006.-Vol.91 (Suppl.1).-P.267.
  • Lara PC, Russell NS, Smolders IJ, et al: Radiation-induced differentiation of human skin fibroblasts: Relationship with cell survival and collagen production. Int J Radiat Biol 70:683-692, 1996
  • Lee C.K.K., Aeppli D.M., Bloomfield C.D., Levitt S.H. Hodgkin's disease: A reassessment of prognostic factors following modification of radiotherapy//Int. J. Radiat. Oncol.-Biol.-Phys.-1987.-Vol.13.-p. 983-991.
  • Lee KH, Kagan AR, Nussbaum II et al. (1976) Analysis of dose, dose-rate and treatment time in production of injuries by radiation treatment for cancer of the uterine cervix. Br J Radiol 49: 430-440
  • Lеpke RA, Libshitz HI (1983) Radiation-induced injury of the esophagus. Radiology 48: 375-378
  • Levis A., Gobbi P.G., Chisesi T. ABVD vs. Stanford vs. MOPP-EVP-CAD in advanced Hodgkin's lymphoma. Results of randomized trial.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
  • Levitt S.H., Lee C.K.K. Dilemmas and decisions//"Int. J. Radiat. Oncol. Biol. Phys.".-1990.-V. 18.-P. 485-488.
  • Loeffler M., Hasenclever D., Sextro M., et al. For the International Database on Hodgkin's disease Overview Study Group: Meta-analysis of chemotherapy versus combined treatment trials in Hodgkin's disease//J. Clin. Oncol.-1998.-v.16.-p.818.
  • Longo D.L. The case against the routine use of radiation therapy in advanced stage Hodgkin's disease//Cancer invest.-1996.-v.14.-p.353.
  • Longo D.L., Glatstein E., Duffey P.L., et al. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease//J. Clin. Oncol.-1997.-v.15.-N.11.-p.3338-3346.
  • Longo D.L., Russo A., Duffey P.L., et al. Treatment of advanced stage massive mediastinal Hodgkin's disease: The cases for combined modality treatment//J. Clin. Oncol.-1991.-v.9.-p.227
  • Mameghan H, Fisher R, Mameghan J el al. (1990) Bowel complications alter radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys 18: 315-320
  • Martinelli G., Cocorocchio E, Peccatori F, at al. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis//Br. J. Haematol., 2004, v. 125(5), p. 584-899.
  • Mathe G., Rappaport H., O'Connor G.T., et al. Histological and cytological typing of neoplastic disease of hematopoietic and lymphoid tissuers/In: WHO International Histological Classification of Tumors.-Geneva: WHO, 1976.-N14.
  • Mauch P.M. Controversies in the management of early stage Hodgkin's disease//Blood.-1994.-v.83.-p.319.
  • Mauch P.M. Management of early stage Hodgkin's disease: The role of radiation therapy and/or chemotherapy//Ann Oncol.-1996.-v.7.-(Suppl.4).-p.79.
  • Mauch P.M., Kalish L.A., Marcus K.S., et al. Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection and cardiovascular disease//Cancer J. Sci. Am.-1995.-v.1.-p.33
  • Mauch P.V., Armitage J.D., Diehl V., et al. Hodgkin's disease//Philadelphia.-1999
  • Mason GR, Dietrich P, Friedland GW et al. (1970) The radiological findings in radiation-induced enteritis and colitis: a review of 30 cases. Clin Radiol 21: 232-247
  • Mendelson RM, Nolan DJ (19.85) The radiological features of chronic radiation enteritis. Clin Radiol 36:141-148
  • Meyer JE (1981) Radiography of the distal colon and rectum after irradiation of carcinoma of the cervix. AJR 136: 691-699
  • Mendenhall N.P., Lynch J.W., Jr'Bennet C.J. Is combined modality therapy necessary for advanced Hodgkin's disease?//Jnt. J. Radiat Oncol. Biol. Phys.-1997.-v.38.-N.3.-p.583-592
  • Mogavero GT, Jones B, Cameron JL et al. (1992) Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy. AJR 159: 1001-1003
  • Morris GM, Coderre JA, Bywaters A, et al: Boron neutron capture irradiation of the rat spinal cord: Histopathological evidence of a vascularmediated pathogenesis. Radiat Res 146:313-320, 1996
  • Mundt A.J., Sibley G., Williams S., et al. Pattern of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease//Jnt. J. Radiat Oncol. Biol. Phys.-1995.-v.33.-N.2.-p.261-270.
  • Pavlovsky S., Santarelli M.T., Sackmann F., et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV Hodgkin's disease//Ann Oncol.-1992.-v.3.-p.533
  • Peter Rodemann, Marcel A. Blaese Responses of Normal Cells to Ionizing Radiation//Radiation oncology. -2007.-P81
  • Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelinpathway. Biochem Pharmacol 53:615-621, 1997
  • Pena LA, Fuks Z, Kolesnick RN: Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60:321-327, 2000
  • Peters V. A study of survival in Hodgkin's disease treated by irradiation//Am. J. Roent.-1950.-v.63.-p.299-311.
  • Phillips TL, Fu KK (1976) Quantification of combined radiation therapy and chemotherapy effects on critical normal tissue. Cancer 37:1186-1200
  • Polish RA, Boen J, Jones TK et al. (1981) Probability models in the analysis of radiation-related complications: utility and limitations. Radiology 140: 203-207
  • Prosnitz L.R., Curtis A.M., Knowlton A.H., et al. Supradiaphragmatic Hodgkin's disease: Significance of large mediastinal masses//Jnt. J. Radiat Oncol. Biol. Phys.-1980.-v.6.-p.809.
  • Prosnitz L.R., Farber L.R., Kapp D.S., et al. Combined modality therapy necessary for advanced stage Hodgkin's disease: 15-year follow-up data//J. Clin Oncol.-1988.-v.6.-N.6.-p.603-612.
  • Prosnitz L.R., Wu J.J., Yahalom J. The case for adjuvant radiation therapy in advanced Hodgkin's disease//Cancer Invest.-1996.-v.14.-p.361.
  • Radford J.A., Cowan R.A., Ryder W.D.J. Four weeks of VAPEC-B chemotherapy before involved field radiotherapy minimizes the relapse rate in early stage, low risk Hodgkin's disease and is not associated with an excess of second malignancy.//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-25.
  • Raemaekers J., Burgers M., Henry-Amar M., et al. Patients with Stage III/IV Hodgkin's Disease in Partial Remission after MOPP/ABV Chemotherapy Have Excellent Prognosis after Additional Involved Field Radiotherapy: Interim Results from the Ongoing EORTC LCG and GPMC Phase III Trial//Ann Oncol.-1996.-v.7.-(Suppl.3).-p.22.-a.070.
  • Rodemann HP, Bamberg M: Cellular basis of radiation-induced fibrosis. Radiother Oncol 35:83-90, 1995
  • Rodemann HP, Peterson HP, Schwenke K, et al: Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 5:1135-1143, 1992
  • Rodemann HP, Binder A, Burger A, et al: The underlying cellular mechanism of fibrosis. Kidney Int 49:32-36, 1996
  • Rodemann HP, Bayreuther K, Francz PI, et al: Selective enrichment and biochemical characterisation of seven fibroblast cell types of human skin fibroblast populations in vitro. Exp Cell Res 180:84-93, 1989
  • Rubin P, Finkelstein J, Schapiro D: Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 24:93-101, 1992
  • Stein H., Diehl V., Marafioti T. et al.//The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular biology in Hodgkin"s Disease/In: Hodgkin"s Disease, Mauch P., Armitage J.O., Diehl V.(eds).-Lippincott Williams & Wilkins: Philadelphia.-1999.-P.121.
  • Sextro M., Diehl V., Franklin I., et al.//Ann. Oncol., 1996, v. 7, p. 61.
  • Sextro M., Lieberz D., Franklin I., et al. For the German Hodgkin's Lymphoma Study Group (GHSG). Liver involvement in Hodgkin's lymphoma: An analysis of 94 consecutive cases//Blood.-1996.-v.88.-(Suppl.1).-p.227a.-(a896).
  • Sieber M., Franklin J., Bredenfeld H., et. al. Assessment of a 14 day variant of the BEACOPP regimen in advanced Hodgkin's Disease: results of pilot-study of the German Hodgkin's Lymphoma Study Group (GHSG).//Ann. of Oncology.-2002.-v13.-suppl.2.-p.-63.
  • Steward J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart//Jnt. J. Radiat Oncol. Biol. Phys.-1995.-v.31.-p.1205.
  • Steel G.G. (ed.) Basic Clinical Radiobiology, Third edition, Hodder Arnold, 2002, 262 P.
  • Strup-Perrot C, Vozenin-Brotons MC, Vandamme M, et al: Expression and activation of MMP-2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol. 41:60-70, 2006
  • Swerdlow A.J., Douglas A.J., Vaughan Hudson G., et al. Risk of second primary cancer of Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation//Br Med J. -1992.-v.304.-p.1137.
  • Tada H, Ogushi F, Tani K, et al: Increased binding of chemotactic capacities of PDGF-BB on fibroblasts in radiation pneumonitis. Radiat Res 159:805-811, 2003
  • Taylor PM, Johnson RJ, Eddleston В et al. (1990) Radiological changes in the gastrointestinal and genitourinary tract follow ing radiotherapy for carcinoma of the cervix. Clin Radiol 41:165-169
  • Travis E.L. Genetic Susceptibility To Late Normal Tissue Injury. Sem Radiation Oncology. 2007. V.17. -P.149-155
  • Van Leeuwenl F.E., Klokman W.J., Hagenbeek A., et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study//J Clin Oncol.-1994.-v.12.-p.312.
  • WHO Handbook for Reporting Results of Cancer Treatment.-Geneva, 1979.-Vol.48
  • Wolf J., Diehl V. Hodgkin's disease -pathogenesis and therapy//Ther. Umsch.-1996.-v.53.-N.2.-p.140-146.
  • Yahalom J., Ryu J., Straus J., et al. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations//J Clin Oncol.-1991.-v.9.-p.2193-2201.
  • Yabalom J. Principles, Indications, and Techniques of Radiation Therapy of Lymphomas/The Lymphomas (Second Edition) Ed. By: Canellos G., Lister T.A., Yaung B. -2006. -P.203-224.
  • Yeoh E, Horowitz M (1988) Radiation enteritis. Br J Hosp Mevv 39:498-504
  • Young R.C., Canellos G.P., Chabner B.A., et al. Patterns of relapse in Hodgkin's disease treated with combination chemotherapy//Cancer.-1978.-v.42.-p.1001-1007
  • Yuhasz M, Laufcr I, Sutton G et al. (1985) Radiography of the small bowel in patients with gynecologic malignancies. AJR 144:303-307
  • Zekri J.M., Mouncey P, Hancock BW. Trials in Advanced Hodgkin's Disease: More than 30 Years Experience of the British National Lymphoma Investigation.//Clin. Lymphoma., 2004, v. 5(3), p. 174-183.
Еще
Статья обзорная
SciUp 2024 © 2024 ©